These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 15450240)

  • 1. Discovery of novel nuclear receptor modulating ligands: an integral role for peptide interaction profiling.
    Pearce KH; Iannone MA; Simmons CA; Gray JG
    Drug Discov Today; 2004 Sep; 9(17):741-51. PubMed ID: 15450240
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ligand-based approach to in silico pharmacology: nuclear receptor profiling.
    Mestres J; Martín-Couce L; Gregori-Puigjané E; Cases M; Boyer S
    J Chem Inf Model; 2006; 46(6):2725-36. PubMed ID: 17125212
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Panning for SNuRMs: using cofactor profiling for the rational discovery of selective nuclear receptor modulators.
    Kremoser C; Albers M; Burris TP; Deuschle U; Koegl M
    Drug Discov Today; 2007 Oct; 12(19-20):860-9. PubMed ID: 17933688
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phage display-derived peptides as therapeutic alternatives to antibodies.
    Ladner RC; Sato AK; Gorzelany J; de Souza M
    Drug Discov Today; 2004 Jun; 9(12):525-9. PubMed ID: 15183160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Molecular dynamics simulations of human LRH-1: the impact of ligand binding in a constitutively active nuclear receptor.
    Burendahl S; Treuter E; Nilsson L
    Biochemistry; 2008 May; 47(18):5205-15. PubMed ID: 18410128
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Designing scaffolds of peptides for phage display libraries.
    Uchiyama F; Tanaka Y; Minari Y; Tokui N
    J Biosci Bioeng; 2005 May; 99(5):448-56. PubMed ID: 16233816
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The flip side: Identifying small molecule regulators of nuclear receptors.
    Schulman IG; Heyman RA
    Chem Biol; 2004 May; 11(5):639-46. PubMed ID: 15157874
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The use of peptides in Diogenesis: a novel approach to drug discovery and phenomics.
    Blume AJ; Beasley J; Goldstein NI
    Biopolymers; 2000; 55(4):347-56. PubMed ID: 11169925
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Conformational adaptation of nuclear receptor ligand binding domains to agonists: potential for novel approaches to ligand design.
    Togashi M; Borngraeber S; Sandler B; Fletterick RJ; Webb P; Baxter JD
    J Steroid Biochem Mol Biol; 2005 Feb; 93(2-5):127-37. PubMed ID: 15860255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Development of antituberculous drugs: current status and future prospects].
    Tomioka H; Namba K
    Kekkaku; 2006 Dec; 81(12):753-74. PubMed ID: 17240921
    [TBL] [Abstract][Full Text] [Related]  

  • 11. G-protein-coupled receptor-focused drug discovery using a target class platform approach.
    Heilker R; Wolff M; Tautermann CS; Bieler M
    Drug Discov Today; 2009 Mar; 14(5-6):231-40. PubMed ID: 19121411
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Principles for modulation of the nuclear receptor superfamily.
    Gronemeyer H; Gustafsson JA; Laudet V
    Nat Rev Drug Discov; 2004 Nov; 3(11):950-64. PubMed ID: 15520817
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of peptide ligands to the chemokine receptor CCR5 and their maturation by gene shuffling.
    Vyroubalova EC; Hartley O; Mermod N; Fisch I
    Mol Immunol; 2006 Apr; 43(10):1573-8. PubMed ID: 16280164
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Importance of molecular computer modeling in anticancer drug development.
    Geromichalos GD
    J BUON; 2007 Sep; 12 Suppl 1():S101-18. PubMed ID: 17935268
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mechanisms of peptide and nonpeptide ligand binding to Class B G-protein-coupled receptors.
    Hoare SR
    Drug Discov Today; 2005 Mar; 10(6):417-27. PubMed ID: 15808821
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Designing peptide receptor agonists and antagonists.
    Hruby VJ
    Nat Rev Drug Discov; 2002 Nov; 1(11):847-58. PubMed ID: 12415245
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nuclear hormone receptor targeted virtual screening.
    Schapira M; Abagyan R; Totrov M
    J Med Chem; 2003 Jul; 46(14):3045-59. PubMed ID: 12825943
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Ligand specificity of nuclear hormone receptors: sifting through promiscuity.
    Noy N
    Biochemistry; 2007 Nov; 46(47):13461-7. PubMed ID: 17983246
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Digging deep into the pockets of orphan nuclear receptors: insights from structural studies.
    Benoit G; Malewicz M; Perlmann T
    Trends Cell Biol; 2004 Jul; 14(7):369-76. PubMed ID: 15246430
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Novel modes of oestrogen receptor agonism and antagonism by hydroxylated and chlorinated biphenyls, revealed by conformation-specific peptide recognition patterns.
    Sumbayev VV; Jensen JK; Hansen JA; Andreasen PA
    Mol Cell Endocrinol; 2008 Jun; 287(1-2):30-9. PubMed ID: 18343567
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.